Telehealth

A forgotten corner of oncology is set for a 14.2% CAGR. A new wave of drugs for chemo-induced neuropathy signals a major market realignment.

Cincinnati Children's and Parkview Health finalize a landmark agreement, promising to reduce travel for families and reshape the regional healthcare market.

The PD-L1 biomarker testing market is set to double by 2036, fueling a revolution in cancer care. But as innovation races ahead, who gets left behind?

With the acquisition of an FDA-cleared app, UpRight Science is turning smartphones into medical devices to predict and prevent falls in older adults.

A new program in Nevada is using breath-based tech to tackle first responder burnout. But can a simple device truly change the complex health of those who serve?

Komodo Health restructures its C-suite, signaling a major shift in healthcare. It's no longer about AI hype; it's about enterprise-scale dominance.

A record $1.15M campaign for blood cancer reveals a new playbook where executive influence, not just corporate checks, drives profound social impact.

Quoin Pharma's new data for a rare skin disease shows life-changing results in children, offering hope for families. What do the numbers really mean?

Beyond a simple rebrand, CTM's new integrations and strategic hires reveal a deeper play to solve the market's biggest data disconnect for modern business.

A new partnership aims to transform care for thousands of dual-eligible residents, moving specialized palliative services from the hospital to the community.

A new partnership between IS3WARE and Privacy Horizon signals a pivotal shift in how our most sensitive sectors will defend against digital and regulatory threats.

Celebrating ten years with record revenue, Waterdrop Inc. doubles down on AI to fuse financial growth with a profound social mission in healthcare.

A new corporate alliance is targeting veteran lung disease. It’s more than a webinar; it’s a strategic response to the PACT Act’s seismic shift.

EcoOnline and J.S. Held's new alliance isn't just another partnership. It’s a blueprint for a future where digital tools and human expertise merge to tackle risk.

BioAge Labs starts a Phase 2 trial for BGE-102, an oral drug targeting inflammation to reduce heart risk, a strategy that could redefine cardiovascular care.

A new pact between Canada’s CASTL and Ireland’s NIBRT, backed by top leaders, aims to solve a critical talent shortage and secure the global pharma supply chain.

Pharma giant MSD and health-tech innovator Nivi are using an AI chatbot to fight cervical cancer in Asia. Can this model overcome regulatory hurdles and scale?

Strive Health's new CMO and CFO hires signal a strategic acceleration in value-based kidney care, blending clinical innovation with financial AI deployment.

The company behind the first FDA-cleared birth control app is expanding into a holistic wellness platform, a strategic move that could redefine the FemTech market.

Verge Labs' new AI model promises to predict brain activity from a blood draw, potentially upending the costly and failure-prone world of neurology R&D.